Moreover, it has been shown that high PD-L1 expression in tumor tissues is correlated with a poor prognosis in HCC patients [53,54,55] and predicts a better response to PD-L1-based therapy in cancer patients [56]. This evidence concerns the gene CD274 and hepatocellular carcinoma.